Leber congenital amaurosis: Can CRISPR cure genetic blindness?
A clinical trial in the United States is looking to cure a type of genetic blindness called Leber congenital amaurosis (LCA) with the use of CRISPR technology.
For more information on this clinical trial please visit:
http://ir.editasmedicine.com/news-releases/news-release-details/allergan-and-editas-medicine-initiate-brilliance-phase-12
This video was made by McMaster Demystifying Medicine students: Iman Adani, Amanpreet Singh, Maham Tariq, Hibo Rijal and Vysh Satyajit.
Copyright McMaster University 2019.
References:
Allergan and Editas Medicine Initiate the Brilliance Phase 1/2 Clinical Trial of AGN-151587 (EDIT101) for the Treatment of LCA10. (n.d.). Retrieved November 7, 2019, from Editas Medicine
website: http://ir.editasmedicine.com/news-releases/news-release-details/allergan-and-editasmedicine-initiate-brilliance-phase-12
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., … Ali, R. R.
(2008). Effect of Gene Therapy on Visual Function in Leber’s Congenital Amaurosis. New
England Journal of Medicine, 358(21), 2231–2239. https://doi.org/10.1056/NEJMoa0802268
Cideciyan, A. V., & Jacobson, S. G. (2019). Leber Congenital Amaurosis (LCA): Potential for
Improvement of Vision. Investigative Ophthalmology & Visual Science, 60(5), 1680–1695.
https://doi.org/10.1167/iovs.19-26672
Gogate, P., Kalua, K., & Courtright, P. (2009). Blindness in Childhood in Developing Countries: Time
for a Reassessment? PLoS Medicine, 6(12). https://doi.org/10.1371/journal.pmed.1000177
Ramirez, V. B. (2019, July 28). First Human CRISPR Trial in the US Aims to Cure Inherited
Blindness. Retrieved October 17, 2019, from Singularity Hub website:
https://singularityhub.com/2019/07/28/first-human-crispr-trial-in-the-us-aims-to-cure-inheritedblindness/
Single Ascending Dose Study in Participants With LCA10—Full Text View—ClinicalTrials.gov.
(n.d.). Retrieved November 7, 2019, from https://clinicaltrials.gov/ct2/show/NCT03872479
Weleber, R. G., Francis, P. J., Trzupek, K. M., & Beattie, C. (1993). Leber Congenital Amaurosis. In
M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, K. Stephens, & A.
Amemiya (Eds.), GeneReviews®. Retrieved from
http://www.ncbi.nlm.nih.gov/books/NBK1298/
Видео Leber congenital amaurosis: Can CRISPR cure genetic blindness? канала Demystifying Medicine
For more information on this clinical trial please visit:
http://ir.editasmedicine.com/news-releases/news-release-details/allergan-and-editas-medicine-initiate-brilliance-phase-12
This video was made by McMaster Demystifying Medicine students: Iman Adani, Amanpreet Singh, Maham Tariq, Hibo Rijal and Vysh Satyajit.
Copyright McMaster University 2019.
References:
Allergan and Editas Medicine Initiate the Brilliance Phase 1/2 Clinical Trial of AGN-151587 (EDIT101) for the Treatment of LCA10. (n.d.). Retrieved November 7, 2019, from Editas Medicine
website: http://ir.editasmedicine.com/news-releases/news-release-details/allergan-and-editasmedicine-initiate-brilliance-phase-12
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., … Ali, R. R.
(2008). Effect of Gene Therapy on Visual Function in Leber’s Congenital Amaurosis. New
England Journal of Medicine, 358(21), 2231–2239. https://doi.org/10.1056/NEJMoa0802268
Cideciyan, A. V., & Jacobson, S. G. (2019). Leber Congenital Amaurosis (LCA): Potential for
Improvement of Vision. Investigative Ophthalmology & Visual Science, 60(5), 1680–1695.
https://doi.org/10.1167/iovs.19-26672
Gogate, P., Kalua, K., & Courtright, P. (2009). Blindness in Childhood in Developing Countries: Time
for a Reassessment? PLoS Medicine, 6(12). https://doi.org/10.1371/journal.pmed.1000177
Ramirez, V. B. (2019, July 28). First Human CRISPR Trial in the US Aims to Cure Inherited
Blindness. Retrieved October 17, 2019, from Singularity Hub website:
https://singularityhub.com/2019/07/28/first-human-crispr-trial-in-the-us-aims-to-cure-inheritedblindness/
Single Ascending Dose Study in Participants With LCA10—Full Text View—ClinicalTrials.gov.
(n.d.). Retrieved November 7, 2019, from https://clinicaltrials.gov/ct2/show/NCT03872479
Weleber, R. G., Francis, P. J., Trzupek, K. M., & Beattie, C. (1993). Leber Congenital Amaurosis. In
M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, K. Stephens, & A.
Amemiya (Eds.), GeneReviews®. Retrieved from
http://www.ncbi.nlm.nih.gov/books/NBK1298/
Видео Leber congenital amaurosis: Can CRISPR cure genetic blindness? канала Demystifying Medicine
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Blindness to Sight: Hannah R.'s StoryCRISPR: What is the future of gene editing? | Start HereHow CRISPR lets us edit our DNA | Jennifer DoudnaCRISPR: Gene editing and beyondHow Gene Editing Is Curing DiseaseRetinal Blindness, Gene Therapy, CRISPR, and Artificial IntelligenceGene Editing for DMDWhat is CRISPR?Helena's Story: Living with Leber Congenital Amaurosis (LCA)Macular Degeneration: The View Ahead in Research and TreatmentGene therapy: bringing new hope to people with vision lossLumevoq Gene Therapy in Leber Hereditary Optic Neuropathy (LHON), M. TaielWhat is Leber’s congenital amaurosis?Usando genes como medicinas | HHMI BioInteractive VideoEyeing Stem Cell Therapies for Vision LossRetinal Research Update - 4/18/2020Gene Therapy for Inherited Retinal DiseasesPneumonia Explained Clearly by MedCram.comCRISPR in Context: The New World of Human Genetic EngineeringThe Realities of Gene Editing with CRISPR I NOVA I PBS